Substance P Dosage Guide
Complete guide to Substance P dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
35 mcg – 350 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
1 weeks
Reconstitution
Vial Size
5 mg
BAC Water
2.0 ml
Concentration
2,500 mcg/ml
Detailed Dosage Information
Not used as a therapeutic agent.
NK1 receptor antagonists (blocking Substance P) are used clinically for chemotherapy-induced nausea.
Administration Method
Research compound only. Therapeutic applications focus on blocking rather than administering Substance P.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 2.5 mg/ml
Volume to inject: 0.077 ml
Syringe units: 7.7 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Substance P defaults. Adjust values as needed.
Side Effects to Monitor
Administration would cause pain, inflammation, and neurogenic responses. Not given therapeutically.
Safety Considerations & Risks
Exogenous administration would be harmful. Research focuses on antagonists not agonists.